Erlotinib Krka

Erlotinib Krka is an oral medication used to treat certain types of cancer. This pharmaceutical is manufactured by Krka, D.D., Novo Mesto, and is designed for targeted therapy.

Erlotinib Krka is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer. It works by targeting specific proteins involved in cancer cell growth. Patients often wonder, 'What is Erlotinib used for?' This medication is part of a class of drugs known as tyrosine kinase inhibitors, which help to slow the progression of cancer.

Common effects of Erlotinib Krka may include skin rash, diarrhea, and fatigue. Some users may also experience appetite loss and nausea. These effects can vary from person to person and are not experienced by everyone who takes the medication.

Erlotinib Krka should be handled with care and stored as directed. It is important to follow the advice of a healthcare professional regarding its use. Patients with certain medical conditions or allergies should inform their healthcare provider before starting this medication.

Erlotinib Krka may interact with other medications, including those that are metabolized by the liver. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain foods may also affect how this medication works.